Abbott
Trade Abbott 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABT
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
ABT Key Statistics
Stock Snapshot
As of today, Abbott(ABT) shares are valued at $109.01. The company's market cap stands at 190.11B, with a P/E ratio of 29.30 and a dividend yield of 2.2%.
During the trading session on 2026-02-01, Abbott(ABT) shares reached a daily high of $109.51 and a low of $105.70. At a current price of $109.01, the stock is +3.1% higher than the low and still -0.5% under the high.
Trading activity shows a volume of 17.53M, compared to an average daily volume of 17.86M.
The stock's 52-week range extends from a low of $105.27 to a high of $141.23.
The stock's 52-week range extends from a low of $105.27 to a high of $141.23.
ABT News
Abbott Laboratories (ABT) is back in focus after its fourth quarter update, where weakness in the Nutrition segment pulled overall sales growth below Wall Stree...
Key Points These companies have a long history of dividend growth, spanning more than 50 years. Passive income is something that rewards investors in any mark...
Abbott Laboratories (NYSE:ABT) is addressing ongoing headwinds in its Nutrition segment with changes to pricing, promotions, and cost structures, with a shift s...
Analyst ratings
71%
of 31 ratingsMore ABT News
Looking at the sectors faring best as of midday Friday, shares of Consumer Products companies are outperforming other sectors, up 0.8%. Within that group, Decke...
Freedom Capital upgraded Abbott (ABT) to Buy from Hold with a price target of $120, down from $130. The firm cites long-term prospects of the company’s Exact Sc...
Abbott Laboratories reported fourth-quarter 2025 sales of US$11,459 million, with net income dropping to US$1,776 million and diluted EPS from continuing operat...
New insider activity at Abbott Laboratories ( (ABT) ) has taken place on January 26, 2026. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and power...
Abbott Laboratories (NYSE:ABT) is pursuing the acquisition of Exact Sciences to expand its presence in cancer diagnostics. The move comes alongside a targeted...
Abbott Laboratories (ABT) shares snapped six straight sessions of losses, as the stock closed 1.2% higher at $108.77 on Monday. The MedTech giant started its d...
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at tw...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.